JPY 2388.0
(0.55%)
Year | Revenue | Revenue Growth |
---|---|---|
2023 | 55.4 Billion JPY | 8.61% |
2022 | 51.01 Billion JPY | 2.79% |
2021 | 49.63 Billion JPY | 0.77% |
2020 | 49.25 Billion JPY | 5.01% |
2019 | 46.9 Billion JPY | 1.8% |
2018 | 46.07 Billion JPY | 0.38% |
2017 | 45.9 Billion JPY | -1.88% |
2016 | 46.78 Billion JPY | 2.25% |
2015 | 45.75 Billion JPY | -2.74% |
2014 | 47.04 Billion JPY | -4.19% |
2013 | 49.1 Billion JPY | 1.0% |
2012 | 48.61 Billion JPY | 9.59% |
2011 | 44.35 Billion JPY | -6.55% |
2010 | 47.46 Billion JPY | 1.95% |
2009 | 46.56 Billion JPY | 1.44% |
2008 | 45.9 Billion JPY | 4.34% |
2007 | 43.99 Billion JPY | 1.9% |
2006 | 43.16 Billion JPY | 1.16% |
2005 | 42.67 Billion JPY | 1.75% |
2004 | 41.93 Billion JPY | 0.0% |
Year | Revenue | Revenue Growth |
---|---|---|
2024 Q1 | 14.62 Billion JPY | 16.26% |
2023 Q2 | 13.91 Billion JPY | 3.04% |
2023 Q1 | 13.5 Billion JPY | 14.5% |
2023 Q4 | 12.57 Billion JPY | -18.36% |
2023 FY | 55.4 Billion JPY | 8.61% |
2023 Q3 | 15.4 Billion JPY | 10.7% |
2022 Q2 | 13 Billion JPY | 5.15% |
2022 Q4 | 11.79 Billion JPY | -14.82% |
2022 Q1 | 12.36 Billion JPY | 8.85% |
2022 Q3 | 13.84 Billion JPY | 6.49% |
2022 FY | 51.01 Billion JPY | 2.79% |
2021 Q4 | 11.36 Billion JPY | -14.61% |
2021 FY | 49.63 Billion JPY | 0.77% |
2021 Q3 | 13.3 Billion JPY | 7.58% |
2021 Q1 | 12.59 Billion JPY | 14.11% |
2021 Q2 | 12.36 Billion JPY | -1.84% |
2020 Q4 | 11.04 Billion JPY | -16.87% |
2020 Q1 | 12.43 Billion JPY | 16.47% |
2020 Q2 | 12.5 Billion JPY | 0.56% |
2020 FY | 49.25 Billion JPY | 5.01% |
2020 Q3 | 13.28 Billion JPY | 6.26% |
2019 FY | 46.9 Billion JPY | 1.8% |
2019 Q4 | 10.67 Billion JPY | -15.0% |
2019 Q2 | 11.92 Billion JPY | 1.51% |
2019 Q1 | 11.74 Billion JPY | 12.41% |
2019 Q3 | 12.55 Billion JPY | 5.29% |
2018 Q3 | 12.67 Billion JPY | 9.31% |
2018 FY | 46.07 Billion JPY | 0.38% |
2018 Q1 | 11.35 Billion JPY | 8.72% |
2018 Q2 | 11.59 Billion JPY | 2.08% |
2018 Q4 | 10.45 Billion JPY | -17.53% |
2017 Q1 | 11.5 Billion JPY | 8.79% |
2017 FY | 45.9 Billion JPY | -1.88% |
2017 Q3 | 12.38 Billion JPY | 7.19% |
2017 Q2 | 11.55 Billion JPY | 0.42% |
2017 Q4 | 10.44 Billion JPY | -15.68% |
2016 Q1 | 11.85 Billion JPY | 13.66% |
2016 FY | 46.78 Billion JPY | 2.25% |
2016 Q4 | 10.57 Billion JPY | -15.26% |
2016 Q3 | 12.48 Billion JPY | 5.2% |
2016 Q2 | 11.86 Billion JPY | 0.14% |
2015 FY | 45.75 Billion JPY | -2.74% |
2015 Q4 | 10.42 Billion JPY | -13.65% |
2015 Q3 | 12.07 Billion JPY | 4.01% |
2015 Q2 | 11.6 Billion JPY | -0.27% |
2015 Q1 | 11.64 Billion JPY | 7.94% |
2014 Q3 | 12.78 Billion JPY | 7.93% |
2014 Q4 | 10.78 Billion JPY | -15.66% |
2014 FY | 47.04 Billion JPY | -4.19% |
2014 Q1 | 11.62 Billion JPY | 4.11% |
2014 Q2 | 11.84 Billion JPY | 1.94% |
2013 Q2 | 12.34 Billion JPY | 1.23% |
2013 Q4 | 11.16 Billion JPY | -16.74% |
2013 FY | 49.1 Billion JPY | 1.0% |
2013 Q1 | 12.19 Billion JPY | 10.32% |
2013 Q3 | 13.4 Billion JPY | 8.65% |
2012 Q3 | 13.43 Billion JPY | 12.12% |
2012 Q4 | 11.05 Billion JPY | -17.78% |
2012 Q1 | 12.13 Billion JPY | 13.79% |
2012 FY | 48.61 Billion JPY | 9.59% |
2012 Q2 | 11.98 Billion JPY | -1.24% |
2011 Q1 | 10.22 Billion JPY | -6.04% |
2011 Q2 | 11.41 Billion JPY | 11.59% |
2011 Q3 | 12.04 Billion JPY | 5.55% |
2011 Q4 | 10.66 Billion JPY | -11.47% |
2011 FY | 44.35 Billion JPY | -6.55% |
2010 Q3 | 12.5 Billion JPY | 2.32% |
2010 Q2 | 12.22 Billion JPY | 3.04% |
2010 FY | 47.46 Billion JPY | 1.95% |
2010 Q4 | 10.88 Billion JPY | -12.92% |
2010 Q1 | 11.85 Billion JPY | 10.34% |
2009 Q1 | 11.6 Billion JPY | 10.89% |
2009 Q4 | 10.74 Billion JPY | -12.35% |
2009 Q3 | 12.26 Billion JPY | 2.69% |
2009 Q2 | 11.94 Billion JPY | 2.9% |
2009 FY | 46.56 Billion JPY | 1.44% |
2008 Q2 | 11.59 Billion JPY | 0.0% |
2008 FY | 45.9 Billion JPY | 4.34% |
2008 Q4 | 10.46 Billion JPY | -14.87% |
2008 Q3 | 12.29 Billion JPY | 6.04% |
2007 FY | 43.99 Billion JPY | 1.9% |
2006 FY | 43.16 Billion JPY | 1.16% |
2005 FY | 42.67 Billion JPY | 1.75% |
2004 FY | 41.93 Billion JPY | 0.0% |
Name | Revenue | Revenue Difference |
---|---|---|
Pharma Foods International Co., Ltd. | 62.14 Billion JPY | 10.847% |
Takeda Pharmaceutical Company Limited | 4263.76 Billion JPY | 98.701% |
Sumitomo Pharma Co., Ltd. | 314.55 Billion JPY | 82.386% |
Shionogi & Co., Ltd. | 435.08 Billion JPY | 87.265% |
Wakamoto Pharmaceutical Co.,Ltd. | 7.73 Billion JPY | -615.985% |
Nippon Shinyaku Co., Ltd. | 148.25 Billion JPY | 62.628% |
Kaken Pharmaceutical Co., Ltd. | 72.04 Billion JPY | 23.094% |
Eisai Co., Ltd. | 741.75 Billion JPY | 92.53% |
Morishita Jintan Co., Ltd. | 12.4 Billion JPY | -346.606% |
Hisamitsu Pharmaceutical Co., Inc. | 141.7 Billion JPY | 60.901% |
Mochida Pharmaceutical Co., Ltd. | 102.88 Billion JPY | 46.148% |
Nippon Chemiphar Co., Ltd. | 30.74 Billion JPY | -80.194% |
Tsumura & Co. | 150.84 Billion JPY | 63.27% |
Kissei Pharmaceutical Co., Ltd. | 75.57 Billion JPY | 26.691% |
Torii Pharmaceutical Co., Ltd. | 54.63 Billion JPY | -1.406% |
Towa Pharmaceutical Co., Ltd. | 227.93 Billion JPY | 75.692% |
Fuji Pharma Co., Ltd. | 40.88 Billion JPY | -35.503% |
Zeria Pharmaceutical Co., Ltd. | 75.72 Billion JPY | 26.833% |
KYORIN Holdings, Inc. | 119.53 Billion JPY | 53.648% |
Taiko Pharmaceutical Co.,Ltd. | 5.04 Billion JPY | -999.325% |
Daito Pharmaceutical Co.,Ltd. | 46.89 Billion JPY | -18.149% |
SymBio Pharmaceuticals Limited | 5.58 Billion JPY | -891.215% |
MedRx Co., Ltd | 26 Million JPY | -213000.0% |
Mizuho Medy Co.,Ltd. | 10.98 Billion JPY | -404.161% |
Solasia Pharma K.K. | 617 Million JPY | -8879.903% |
Modalis Therapeutics Corporation | - JPY | -Infinity% |
ASKA Pharmaceutical Holdings Co.,Ltd. | 62.84 Billion JPY | 11.834% |
Sawai Group Holdings Co., Ltd. | 176.86 Billion JPY | 68.673% |
Cyfuse Biomedical K.K. | 61.11 Million JPY | -90563.045% |
Toho Holdings Co., Ltd. | 1476.71 Billion JPY | 96.248% |
Koa Shoji Holdings Co.,Ltd. | 22.13 Billion JPY | -150.319% |